Corbus Pharmaceuticals Holding (CRBP)

Corbus Pharmaceuticals Holding (CRBP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $85.5M; returns 1 day -1.9%, 1 week -10.4%, 1 year -76.7%.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting well-understood biological pathways in oncology and obesity. The company generates minimal revenue from operations, primarily through grants, licensing deals, and limited milestone payments, as it remains pre-commercial with no approved products.

Groups CRBP belongs to

• Clinical Stage Biopharma
• Biotechnology
• Clinical Stage
• Healthcare
• Antibody-Drug Conjugates
• Oncology
• Weight Management
• R&D
• Life Sciences
• Monoclonal Antibodies

CRBP financial model: income statement, cash flow and balance sheet